Supplementary Figure from USP22 Interacts with PALB2 and Promotes Chemotherapy Resistance via Homologous Recombination of DNA Double-Strand Breaks

Supplementary Figure 1</p

Supplemental Figure Legend from USP22 Interacts with PALB2 and Promotes Chemotherapy Resistance via Homologous Recombination of DNA Double-Strand Breaks

Supplemental Figure Legend</p

Additional file 2 of Transcription factor AP2 enhances malignancy of non-small cell lung cancer through upregulation of USP22 gene expression

Additional file 1. Supplementary figures and tables

Supplementary Figures S1-S6 from G9a Promotes Invasion and Metastasis of Non–Small Cell Lung Cancer through Enhancing Focal Adhesion Kinase Activation via NF-κB Signaling Pathway

Figure S1. G9a silencing suppressed cell proliferation in A549 and H1299 NSCLCs Figure S2. Cell migration and invasion was suppressed in NSCLCs treated by G9a inhibitor UNC0638 Figure S3. G9a overexpression increased cell proliferation in NSCLCs Figure S4. FAK inhibitor attenuates the enhanced cell migration and invasion by G9a overexpression Figure S5. knockdown of G9a suppressed tumor metastasis in vivo. Figure S6. NF-kappa;B signaling pathway is independent of Wnt signaling pathway.</p

Figure S1 from Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma

Immunofluorescence of CD133 and USP22/H2Bub1</p

Figure S2 from Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma

USP22 knockdown with another USP22-shRNA</p

Supplementary Data from A Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinoma

Supplementary Data from A Multigene Assay Is Prognostic of Survival in Patients with Early-Stage Lung Adenocarcinom

Figure S4 from Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma

Correlation between the levels of USP22 mRNA with that of ALDH1A3 mRNA in lung Adenocarcinoma tissues from TCGA portal</p

Figure S3 from Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma

Knockdown of USP22 in A549, H1299, and H838 lung cancer cells significantly down-regulated ALDH1A3 mRNA expression in these cells</p

Figure S5 from Targeting USP22 Suppresses Tumorigenicity and Enhances Cisplatin Sensitivity Through ALDH1A3 Downregulation in Cancer-Initiating Cells from Lung Adenocarcinoma

Correlation between the levels of CD133 (PROM1) mRNA with that of ALDH1A3 mRNA in lung adenocarcinoma tissues from TCGA portal</p